17-AAG and Irinotecan in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Summary

This phase I trial is studying the side effects and best dose of 17-AAG and irinotecan in treating patients with locally advanced or metastatic solid tumors. Drugs used in chemotherapy, such as 17-AAG and irinotecan, work in different ways to stop the growth of tumor cells either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.

Timeline

Start

2005-05

Primary completion

2008-10

Completion

—

Drugs

Indications